286 related articles for article (PubMed ID: 31342400)
1. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
[TBL] [Abstract][Full Text] [Related]
2. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
3. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT
Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789
[TBL] [Abstract][Full Text] [Related]
6. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.
Lee RM; Ethun CG; Zaidi MY; Tran TB; Poultsides GA; Grignol VP; Howard JH; Bedi M; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Oskouei SV; Monson DK; Reimer NB; Maithel SK; Cardona K
Surg Oncol; 2020 Sep; 34():292-297. PubMed ID: 32891345
[TBL] [Abstract][Full Text] [Related]
7. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
[TBL] [Abstract][Full Text] [Related]
8. Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.
Chouliaras K; Patel N; Senehi R; Ethun CG; Poultsides G; Grignol V; Gamblin TC; Roggin KK; Fields RC; D'Agostino R; Levine EA; Cardona K; Votanopoulos K
J Surg Oncol; 2021 Feb; 123(2):479-488. PubMed ID: 33150594
[TBL] [Abstract][Full Text] [Related]
9. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.
Patel SA; Royce TJ; Barysauskas CM; Thornton KA; Raut CP; Baldini EH
Ann Surg Oncol; 2017 Jun; 24(6):1588-1595. PubMed ID: 28058559
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival.
Shelby RD; Suarez-Kelly LP; Yu PY; Hughes TM; Ethun CG; Tran TB; Poultsides G; King DM; Bedi M; Mogal H; Clarke C; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Howard JH; Cardona K; Grignol V
J Surg Oncol; 2020 Jun; 121(8):1249-1258. PubMed ID: 32232871
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in patients undergoing neoadjuvant radiation for trunk and extremity soft tissue sarcoma.
Tortorello GN; Sharon CE; Ma KL; Perry N; Shabason JE; Maki RG; Miura JT; Karakousis GC
J Surg Oncol; 2023 Sep; 128(4):628-634. PubMed ID: 37148468
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
13. The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.
Broecker JS; Ethun CG; Monson DK; Lopez-Aguiar AG; Le N; McInnis M; Godette K; Reimer NB; Oskouei SV; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2017 Nov; 24(12):3574-3586. PubMed ID: 28895084
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
17. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
18. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
[TBL] [Abstract][Full Text] [Related]
19. The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative.
Zaidi MY; Ethun CG; Liu Y; Poultsides G; Howard JH; Mogal H; Tseng J; Votanopoulos K; Fields RC; Cardona K
J Surg Oncol; 2019 Sep; 120(3):332-339. PubMed ID: 31172536
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience.
Assi T; Cavalcanti A; Le Cesne A; Faron M; Honart JF; Hadiji A; Camuzard O; Ibrahim T; LePéchoux C; Mir O; Dumont S; Terrier P; Adam J; Honoré C
Clin Transl Oncol; 2019 Sep; 21(9):1135-1141. PubMed ID: 30656606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
